Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Aggression × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 96 Ovarian Neoplasms 57 Neoplasms 54 Fallopian Tube Neoplasms 37 Lung Neoplasms 31 Breast Neoplasms 28 Carcinoma, Ovarian Epithelial 25 Neoplasm Metastasis 19 Small Cell Lung Carcinoma 16 Triple Negative Breast Neoplasms 15 Esophageal Neoplasms 15 Colorectal Neoplasms 15 Advanced Solid Tumors 14 Endometrial Neoplasms 13 Unspecified Adult Solid Tumor, Protocol Specific 12 Squamous Cell Carcinoma of Head and Neck 12 Stomach Neoplasms 11 Pancreatic Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 10 Uterine Cervical Neoplasms 9 Melanoma 9 Central Nervous System Neoplasms 9 Carcinoma 9 Astrocytoma 9 Solid Tumors 8 Medulloblastoma 8 Head and Neck Neoplasms 8 Brain Neoplasms 8 Sarcoma 7 Prostatic Neoplasms 7

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡